The Epigenetic Reign of Intestinal Homeostasis and Aberrancies therein in Celiac Disease
Description of the granted funding
In celiac disease the main hallmark of the disease is the defectively differentiated intestinal epithelium which leads to food malabsorption. We have discovered that epigenetic gene-silencer, called polycomb, controls the intestinal homeostasis between intestinal stem cells in crypts and mature epithelium in villi. In response to gluten ingestion, consequent aberrant polycomb activity was found to cause imbalance in intestinal homeostasis (Oittinen et al. 2016 Stem Cells). Lifelong gluten-free diet (GFD) is the only accepted treatment option for patients with celiac disease. In refractory celiac (RCD) patients even rigid adherence to GFD is not remedial and in untreated type II RCD cases prognosis is very poor with 44-58% 5-year survival rate. In this project we seek to study the function of these epigenetically dysregulated genes in celiac disease. We anticipate that the results will reveal novel pathogenic mechanisms and improve the diagnosis of the early celiac disease.
Show moreStarting year
2017
End year
2022
Granted funding
Related funding decisions
314190
Research costs of Academy Research Fellows(2017)
151 120 €
326395
Research costs of Academy Research Fellows(2019)
178 880 €
335456
Research costs of Academy Research Fellows(2020)
200 000 €
326385
Academy research fellows(2019)
324 170 €
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Other information
Funding decision number
310011
Fields of science
Biomedicine
Research fields
Biolääketieteet
Identified topics
molecular biology, biochemistry